Stifel Reiterates Buy Rating on Crinetics (CRNX)
Stifel analyst Alex Thompson reiterated a Buy rating and $83.00 price target on Crinetics (NASDAQ: CRNX).The analyst commented, " We ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
